EVMS Home Secondary Page Menubar
Department Information
Education
Research
Special Programs
Full-Time Faculty and Researchers
* Ann E. Campbell, Ph.D.
* Richard P. Ciavarra, Ph.D.
* Dianne C. Daniel, Ph.D.
* Richard R. Drake, Ph.D.
* Aurora Esquela-Kerscher, Ph.D.
* Laura K. Hanson, Ph.D.

* Julie A. Kerry, Ph.D.
* Woong-Ki Kim, Ph.D.
* Neel K. Krishna, Ph.D.

* Patric S. J. Lundberg, Ph.D.
* O. John Semmes, Ph.D.
* Julius O. Nyalwidhe, Ph.D.
* Margaret J. Wortman, Ph.D.
* William J. Wasilenko, Ph.D.
Staff
Dept. Directory

Dept. of Microbiology & Molecular Cell Biology

------------------

Julie A. Kerry, Ph.D.Julie A. Kerry, Ph.D.
Associate Professor

Lewis Hall, #3152
Office: (757) 446-5663

Email: kerryja@evms.edu

Teaching: Molecular and Cellular Biology, Cell Biology, Virology and Tumor Biology

Biomedical Sciences Program Track: Molecular Integrative Biosciences (MIB)

#########

Education

  • B.S., South Australian Institute of Technology, Australia
  • M.S., South Australian Institute of Technology, Australia
  • Ph.D., Monash University, Australia
  • Postdoctoral Training, University of California, Santa Barbara
Research Interests

Dr. Kerry's studies are designed to characterize the virus-host cell interactions required for the replication of human cytomegalovirus (HCMV). HCMV is a significant human pathogen, causing severe morbidity and mortality in congenitally infected infants and immunocompromised individuals. However, despite the growing problem of HCMV disease, very little progress has been made in understanding how viral early genes are activated at the molecular level.

The laboratory focuses on the assessment of viral and cellular factors involved in HCMV gene expression. In particular, these studies analyze the mechanism of action of two important viral transcriptional regulators: IE86 and pp71. Characterization of these factors and their interactions with cellular proteins involved in viral gene regulation will greatly enhance the fundamental understanding of the regulatory events governing viral gene expression. These studies may therefore reveal novel strategies for antiviral therapies designed to inhibit viral gene expression.

Selected Publications

  • Ciocco-Schmitt, G. M., Karabekian, Z., Godfrey, E. W., Stenberg, R. M., Campbell, A. E. and Kerry, J. A. Identification and Characterization of Novel Murine Cytomegalovirus M112-113 (e1) Gene Products. Virology, 294, 199-208. 2002.
     
  • McWatters, B. J. P., Stenberg, R. M. and Kerry, J. A. Characterization Of The Human Cytomegalovirus UL75 (glycoprotein H) Late Gene Promoter. Virology, 303, 309-316. 2002.
     
  • Chau, N. H., Vanson, C. D., and Kerry, J. A. Transcriptional Regulation of the Human Cytomegalovirus US11 Early Gene. Journal of Virology 73:863-870. 1999.
     
  • Johnstone, R. W., Kerry, J. A., and Trapani, J. A. The Human Interferon-Inducible Protein, IFI16, is a Repressor of Transcription. Journal of Biological Chemistry 273: 17172-17177, 1998.
     
  • Kerry, J.A., Priddy, M.A., Staley, T.L., Jones, T.R. and Stenberg, R.M. The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection. Journal of Virology 71:2120-2126, 1997.

Top

Home / Site Map / Search / About EVMS / Patient Services
Education / Research / Departments / Library

Feedback / Copyright © 1999-2008 Eastern Virginia Medical School
Revised: April 18, 2008